Auswahl der wissenschaftlichen Literatur zum Thema „Acute exacerbation of interstitial lung diseases“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Acute exacerbation of interstitial lung diseases" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Acute exacerbation of interstitial lung diseases"
Aritonang, Rachel S., Fanny Fachrucha, Mia Elhidsi und Ginanjar Arum Desianti. „Oxygen Therapy in Exacerbation of Interstitial Lung Disease“. Respiratory Science 4, Nr. 3 (28.06.2024): 221–31. http://dx.doi.org/10.36497/respirsci.v4i3.129.
Der volle Inhalt der QuelleKolb, Martin, Benjamin Bondue, Alberto Pesci, Yasunari Miyazaki, Jin Woo Song, Nitin Y. Bhatt, John T. Huggins et al. „Acute exacerbations of progressive-fibrosing interstitial lung diseases“. European Respiratory Review 27, Nr. 150 (21.12.2018): 180071. http://dx.doi.org/10.1183/16000617.0071-2018.
Der volle Inhalt der QuelleAbo Elwafa, GihanS, NaglaaB Ahmed, AmanyA Abou Zeid und MaiA Abo Elhasab. „Noninvasive ventilation in acute exacerbation of interstitial lung diseases“. Egyptian Journal of Chest Diseases and Tuberculosis 72, Nr. 1 (2023): 99. http://dx.doi.org/10.4103/ecdt.ecdt_40_22.
Der volle Inhalt der QuelleDrakopanagiotakis, Fotios, Philipp Markart und Paschalis Steiropoulos. „Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers“. International Journal of Molecular Sciences 24, Nr. 12 (15.06.2023): 10196. http://dx.doi.org/10.3390/ijms241210196.
Der volle Inhalt der QuelleDrakopanagiotakis, Fotios, Ekaterina Krauss, Ira Michailidou, Vasileios Drosos, Stavros Anevlavis, Andreas Günther und Paschalis Steiropoulos. „Lung Cancer and Interstitial Lung Diseases“. Cancers 16, Nr. 16 (13.08.2024): 2837. http://dx.doi.org/10.3390/cancers16162837.
Der volle Inhalt der QuelleMatsunashi, Atsushi, Kazuma Nagata, Takeshi Morimoto und Keisuke Tomii. „Mechanical ventilation for acute exacerbation of fibrosing interstitial lung diseases“. Respiratory Investigation 61, Nr. 3 (Mai 2023): 306–13. http://dx.doi.org/10.1016/j.resinv.2023.01.008.
Der volle Inhalt der QuellePapanikolaou, Ilias C., Fotios Drakopanagiotakis und Vlasis S. Polychronopoulos. „Acute exacerbations of interstitial lung diseases“. Current Opinion in Pulmonary Medicine 16, Nr. 5 (September 2010): 480–86. http://dx.doi.org/10.1097/mcp.0b013e32833ae49d.
Der volle Inhalt der QuelleAkulkina, L. A., M. Yu Brovko, A. A. Schepalina, V. I. Sholomova, A. A. Kitbalian, A. S. Moiseev, P. P. Potapov und S. V. Moiseev. „A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease“. PULMONOLOGIYA 32, Nr. 5 (21.09.2022): 763–69. http://dx.doi.org/10.18093/0869-0189-2022-32-5-763-769.
Der volle Inhalt der QuelleMagdy, Mohammed, Zainab Saaed, Emad Abd El-Aleem und Madyan Mahmoud. „Clinical and radiological signs of acute exacerbation of interstitial lung diseases“. Minia Journal of Medical Research 30, Nr. 3 (01.07.2019): 116–19. http://dx.doi.org/10.21608/mjmr.2022.221906.
Der volle Inhalt der QuelleIto, Yoko, Gen Tazaki, Yusuke Kondo, Genki Takahashi und Fumio Sakamaki. „Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases“. Respiratory Medicine Case Reports 26 (2019): 317–20. http://dx.doi.org/10.1016/j.rmcr.2019.02.021.
Der volle Inhalt der QuelleDissertationen zum Thema "Acute exacerbation of interstitial lung diseases"
Berrube, Élise. „Patient self-inflicted lung injury et ventilator induced lung injury : De l'insuffisance respiratoire aiguë de novo à l'exacerbation aiguë de pneumopathie intersititielle diffuse“. Electronic Thesis or Diss., Normandie, 2024. http://www.theses.fr/2024NORMR030.
Der volle Inhalt der QuelleIntroductionIn the course of de novo acute respiratory failure (ARF) or acute respiratory distress syndrome (ARDS), invasive mechanical ventilation (IMV) and spontaneous respiratory efforts, may paradoxically worsen initial alveolar lesions and cause ventilator induced lung injury (VILI) or patient self-inflicted lung injury (P-SILI). Acute exacerbation of diffuse interstitial lung disease (AE-ILD) presents similar characteristics to ARDS in semiology, histology and radiology. However, the risk of mortality remains higher in AE-ILD despite improved knowledge of VILI and P-SILI. MethodsWe were interested in the effects of ventilation and spontaneous respiratory effort during AE-ILD.ResultsWe first studied the effects of non-invasive oxygenation strategies during de novo ARF, and showed that non-invasive ventilation (NIV) increased tidal volume compared to high flow nasal canulae oxygen therapy (HFNC) without increasing alveolar recruitment, thus exposing the lung to the risk of overdistention. We then developed a mechanical artificial lung model reproducing spontaneous ventilation during de novo ARF and studied the pathophysiological mechanisms involved in P-SILI.We then used this knowledge learned from de novo ARF to model spontaneous ventilation in patients with ILD at rest, during maximal exercise and AE-ILD. We demonstrated that the inhomogeneity of lung injury and of compliance in ILD was associated during exercise and AE-ILD, with the presence of mechanisms involved in P-SILI: recruitment/derecruitment, overdistension, stress concentration and Pendelluft phenomenon.We then exposed this AE-ILD model to the challenges of IMV. We showed that IMV applied with tidal volumes of more than 5 ml/kg PBW, positive expiratory pressure levels of more than 4 cmH2O and respiratory rates of more than 25 cpm were deleterious in our model. At the same time, we evaluated the effects of non-invasive oxygenation strategies during AE-ILD in a retrospective clinical study. We found no difference between NIV and HFNC in mortality or use of invasive ventilation. ConclusionOur research has highlighted the occurence of P-SILI and VILI during AE-ILD and has shown a major risk of overdistension in AE-ILD during IMV. Our model of AE-ILD could help us to develop optimized and personalized oxygenation strategies for AE-ILD patients
Bücher zum Thema "Acute exacerbation of interstitial lung diseases"
Millar, Professor Ann B., Dr Richard Leach, Dr Rebecca Preston, Dr Richard Leach, Dr Richard Leach, Dr Wei Shen Lim, Dr Richard Leach et al. Respiratory diseases and respiratory failure. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199565979.003.0005.
Der volle Inhalt der QuelleBuchteile zum Thema "Acute exacerbation of interstitial lung diseases"
Lazor, Romain, und Marie-Eve Müller. „Organizing Pneumonias and Acute Interstitial Pneumonia“. In Orphan Lung Diseases, 605–26. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-12950-6_35.
Der volle Inhalt der QuelleNtiamoah, Prince, Russell Purpura, Susan Vehar, Curtis J. Coley, Jennifer Hasvold, Lindsay A. Schmidt, Kevin R. Flaherty und Leslie B. Tolle. „Nonspecific, Unclassifiable, and Rare Idiopathic Interstitial Pneumonia: Acute Interstitial Pneumonia, Respiratory Bronchiolitis Interstitial Pneumonia, Desquamative Interstitial Pneumonia, Nonspecific Interstitial Pneumonia“. In Orphan Lung Diseases, 589–603. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-12950-6_34.
Der volle Inhalt der QuelleColey, Curtis J., Leslie B. Tolle, Jennifer Hasvold, Lindsay A. Schmidt und Kevin R. Flaherty. „Non-specific, Unclassifiable, and Rare Idiopathic Interstitial Pneumonia: Acute Interstitial Pneumonia, Respiratory Bronchiolitis Interstitial Pneumonia, Desquamative Interstitial Pneumonia, Nonspecific Interstitial Pneumonia“. In Orphan Lung Diseases, 349–62. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-2401-6_23.
Der volle Inhalt der QuelleDate, Hiroshi. „Acute Exacerbation of Interstitial Pneumonia After Pulmonary Resection for Lung Cancer“. In Idiopathic Pulmonary Fibrosis, 249–59. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55582-7_15.
Der volle Inhalt der QuelleLichtenstein, Daniel A. „BLUE-Protocol and Bronchial Diseases: Acute Exacerbation of COPD (AECOPD) and Severe Asthma“. In Lung Ultrasound in the Critically Ill, 187–88. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-15371-1_25.
Der volle Inhalt der Quelle„Acute Exacerbation of Interstitial Lung Disease“. In Specialty Imaging: HRCT of the Lung, 266–69. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-323-52477-3.50082-2.
Der volle Inhalt der QuelleSimonds, Anita K. „Long-term oxygen therapy/ventilation and cardiovascular outcomes in chronic lung and respiratory diseases“. In ESC CardioMed, 1047–50. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0252.
Der volle Inhalt der QuelleKim, Dong Soon. „Acute Exacerbations in Patients With Idiopathic Pulmonary Fibrosis“. In Interstitial Lung Disease, 131–39. Elsevier, 2018. http://dx.doi.org/10.1016/b978-0-323-48024-6.00011-2.
Der volle Inhalt der QuelleSinharay, Rudy. „Chest Medicine“. In Oxford Assess and Progress: Clinical Medicine. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198812968.003.0009.
Der volle Inhalt der QuelleBhalla, Ashu, und Manisha Jana. „Acute Diffuse Lung Diseases: Imaging“. In Clinico Radiological Series: Imaging of Interstitial Lung Diseases, 279. Jaypee Brothers Medical Publishers (P) Ltd., 2018. http://dx.doi.org/10.5005/jp/books/13047_22.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Acute exacerbation of interstitial lung diseases"
Silva Guerra, Sónia Isabel, Mariana Conceição, Ângela Cunha, Joana Correia, Jorge Vale, Carla António und António Simões Torres. „Acute exacerbation admissions of fibrosing interstitial lung diseases – 3 years study“. In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4739.
Der volle Inhalt der QuelleArtaud Macari, Elise, Emeline Fresnel, Adrien Kerfourn, Christian Caillard, Robin Thévenin, Clemence Roussel, David Debeaumont et al. „Modeling lung ventilation in acute exacerbation of interstitial lung diseases: a bench study“. In ERS International Congress 2023 abstracts. European Respiratory Society, 2023. http://dx.doi.org/10.1183/13993003.congress-2023.pa1219.
Der volle Inhalt der QuelleSuzuki, A., Y. Kondoh, K. K. Brown, T. Kimura, K. Kataoka, T. Matsuda, T. Yokoyama et al. „Recurrent Acute Exacerbations of Fibrotic Interstitial Lung Diseases“. In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5621.
Der volle Inhalt der QuelleTrachalaki, Athina, Eliza Tsitoura, Eirini Vasarmidi, Eleni Bibaki, Nikolaos Tzanakis und Katerina Antoniou. „Inflammasomes activation in alveolar macrophages and peripheral blood mononuclear cells in fibrotic Interstitial Lung Diseases“. In Abstracts from the 17th ERS Lung Science Conference: ‘Mechanisms of Acute Exacerbation of Respiratory Disease’. European Respiratory Society, 2019. http://dx.doi.org/10.1183/23120541.lungscienceconference-2019.pp127.
Der volle Inhalt der QuelleOhshimo, Shinichiro, Yoshiko Kida, Michihito Kyo, Yasushi Horimasu, Hiroshi Iwamoto, Kazunori Fujitaka, Hironobu Hamada et al. „Extracorporeal membrane oxygenation for the treatment of acute exacerbation of interstitial lung diseases“. In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.oa3396.
Der volle Inhalt der QuelleMochizuka, Y., M. Kono, K. Miyashita, R. Hirama, K. Takeda, M. Katsumata, A. Tsutsumi et al. „Recurrence of Acute Exacerbation in Patients with Interstitial Lung Disease“. In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3063.
Der volle Inhalt der QuelleHosoki, Keisuke, Yu Mikami, Taisuke Jo, Kunihiko Soma, Hirokazu Urushiyama und Takahide Nagase. „Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study“. In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.oa5327.
Der volle Inhalt der QuelleRamos Martins, M., D. Barros-Coelho, P. Ribeirinho-Soares, A. Terras-Alexandre, N. Melo, P. Caetano-Mota, H. Novais-Bastos und A. Morais. „Clinical outcomes of patients with acute exacerbations in interstitial lung diseases“. In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.4266.
Der volle Inhalt der QuelleAvera, S., I. Ogbuka, S. El-Chemeitelli und R. G. Karunakara. „Acute Exacerbation of Interstitial Lung Disease in the Setting of COVID-19“. In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1456.
Der volle Inhalt der QuelleFuruta, Katsuyuki, Daichi Fujimoto, Atsushi Matsunashi, Masanori Tanaka, Ryota Shibaki, Yuri Shimada, Kazuma Nagata, Keisuke Tomii und Nobuyuki Yamamoto. „Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease“. In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2241.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Acute exacerbation of interstitial lung diseases"
Kuroda, Hiroaki. Presurgical heterogeneity of lung 18FDG-PET uptake predicts acute exacerbation of interstitial lung disease following pulmonary resection in patients with smoke exposures. Science Repository OU, Juli 2019. http://dx.doi.org/10.31487/j.jso.2019.02.08.
Der volle Inhalt der QuelleHe, Xing, Jiaqi Ji, Dan Zheng, Zeli Luo, Linjie Luo und Lu Guo. Serum surfactant protein D as a significant biomarker for predicting occurrence, progression, acute exacerbation and mortality in patients with interstitial lung disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2024. http://dx.doi.org/10.37766/inplasy2024.5.0050.
Der volle Inhalt der QuelleZheng, Dan, Xing He, Jiaqi Ji, Zeli Luo, Linjie Luo und Lu Guo. Surface protein A as an important biomarker for interstitial lung disease in the assessment of occurrence, progression, acute exacerbation and mortality: a systemic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2024. http://dx.doi.org/10.37766/inplasy2024.5.0092.
Der volle Inhalt der Quelle